These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20649903)

  • 1. Clinical features of patients with blepharospasm: a report of 240 patients.
    Peckham EL; Lopez G; Shamim EA; Richardson SP; Sanku S; Malkani R; Stacy M; Mahant P; Crawley A; Singleton A; Hallett M
    Eur J Neurol; 2011 Mar; 18(3):382-6. PubMed ID: 20649903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign essential blepharospasm among residents of Olmsted County, Minnesota, 1976 to 1995: an epidemiologic study.
    Bradley EA; Hodge DO; Bartley GB
    Ophthalmic Plast Reconstr Surg; 2003 May; 19(3):177-81. PubMed ID: 12918550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign essential blepharospasm: risk factors with reference to hemifacial spasm.
    Hall TA; McGwin G; Searcey K; Xie A; Hupp SL; Owsley C; Kline LB
    J Neuroophthalmol; 2005 Dec; 25(4):280-5. PubMed ID: 16340493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered functional connectivity in blepharospasm/orofacial dystonia.
    Jochim A; Li Y; Gora-Stahlberg G; Mantel T; Berndt M; Castrop F; Dresel C; Haslinger B
    Brain Behav; 2018 Jan; 8(1):e00894. PubMed ID: 29568690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
    Lu R; Huang R; Li K; Zhang X; Yang H; Quan Y; Li Q
    Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin in Meige's syndrome: A video-based case series.
    Pandey S; Sharma S
    Neurol India; 2018; 66(1):71-76. PubMed ID: 29322963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features of Benign Essential Blepharospasm in Korean Patients.
    Lee JM; Baek JS; Choi HS; Kim SJ; Jang JW
    Korean J Ophthalmol; 2018 Oct; 32(5):339-343. PubMed ID: 30311455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P; Chaudhary M; Agrawal JP; Shah DN
    Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
    Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
    Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blepharospasm in children and adolescents.
    Kinard K; Miller NR; Digre KB; Katz BJ; Crum AV; Warner JE
    Childs Nerv Syst; 2016 Feb; 32(2):355-8. PubMed ID: 26510653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy.
    Alexandru H; Muthuraman M; Chirumamilla VC; Koirala N; Paktas B; Deuschl G; Zeuner KE; Groppa S
    PLoS One; 2016; 11(12):e0168652. PubMed ID: 27992533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blepharospasm and oromandibular dystonia (Meige's syndrome) in sisters.
    Nutt JG; Hammerstad JP
    Ann Neurol; 1981 Feb; 9(2):189-91. PubMed ID: 7235635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for spread of primary adult onset blepharospasm: a multicentre investigation of the Italian movement disorders study group.
    Defazio G; Berardelli A; Abbruzzese G; Coviello V; Carella F; De Berardinis MT; Galardi G; Girlanda P; Maurri S; Mucchiut M; Albanese A; Basciani M; Bertolasi L; Liguori R; Tambasco N; Santoro L; Assennato G; Livrea P
    J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):613-9. PubMed ID: 10519867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
    Tolosa E; Martí MJ
    Adv Neurol; 1988; 49():73-84. PubMed ID: 3278555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of glaucoma among patients with benign essential blepharospasm.
    Lee MS; Harrison AR; Grossman DS; Sloan FA
    Ophthalmic Plast Reconstr Surg; 2010; 26(6):434-7. PubMed ID: 20724866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closely spaced stressful life events precede the onset of benign essential blepharospasm and hemifacial spasm.
    Johnson LN; Lapour RW; Johnson GM; Johnson PJ; Madsen RW; Hackley SA
    J Neuroophthalmol; 2007 Dec; 27(4):275-80. PubMed ID: 18090560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of upper eyelid myectomy on subsequent chemodenervation in the management of benign essential blepharospasm.
    Kent TL; Petris CK; Holds JB
    Ophthalmic Plast Reconstr Surg; 2015; 31(3):222-6. PubMed ID: 25192329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystonic frowning without blepharospasm.
    Hirota N; Hirota M; Mezaki T
    Parkinsonism Relat Disord; 2008 Nov; 14(7):579-80. PubMed ID: 18316230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment.
    Pandey S; Sharma S
    J Neurol Sci; 2017 Jan; 372():162-170. PubMed ID: 28017205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dry eye syndrome in benign essential blepharospasm.
    Girard BC; Lévy P
    J Fr Ophtalmol; 2019 Dec; 42(10):1062-1067. PubMed ID: 31733914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.